Development of H51Y and E157Q mutations for integrase inhibitor resistance in a patient undergoing treatment for pulmonary tuberculosis: A case report.
Luís Arthur Brasil Gadelha FariasMelissa Fiuza SaboyaNatália Ponte FernandesLauro Vieira Perdigão NetoErico Antonio Gomes de ArrudaPublished in: SAGE open medical case reports (2023)
Attention when determining the antiretroviral therapy treatment regimen of HIV/TB coinfected patients is paramount. Poor adherence to antiretroviral therapy and follow-up may have contributed to treatment failure and resistance.
Keyphrases
- antiretroviral therapy
- hiv infected
- pulmonary tuberculosis
- human immunodeficiency virus
- hiv positive
- hiv aids
- mycobacterium tuberculosis
- hiv infected patients
- metabolic syndrome
- newly diagnosed
- combination therapy
- adipose tissue
- type diabetes
- case report
- prognostic factors
- replacement therapy
- skeletal muscle
- insulin resistance
- hiv testing
- smoking cessation